The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans-Reference-Cited by-同舟云学术

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

Published:2012-06-01 Issue:6 Volume:122 Page:2176-2194
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Benhamed Fadila,Denechaud Pierre-Damien,Lemoine Maud,Robichon Céline,Moldes Marthe,Bertrand-Michel Justine,Ratziu Vlad,Serfaty Lawrence,Housset Chantal,Capeau Jacqueline,Girard Jean,Guillou Hervé,Postic Catherine

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference92 articles.

1. Recent advances in nonalcoholic fatty liver disease

2. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

3. Nonalcoholic Fatty Liver Disease as a Complication of Insulin Resistance

4. Nonalcoholic fatty liver disease: A review of current understanding and future impact

5. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

2. Optimal fasting duration for mice as assessed by metabolic status;Scientific Reports;2024-09-14

3. Hexokinase regulates Mondo-mediated longevity via the PPP and organellar dynamics;2024-09-03

4. Hepatocyte-specific loss of melanocortin 1 receptor disturbs fatty acid metabolism and promotes adipocyte hypertrophy;International Journal of Obesity;2024-08-08

5. Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH;Molecular Metabolism;2024-07